Baxter wins FDA nod for Spectrum IQ infusion system

This article was originally published here

Baxter (NYSE:BAX) said today that it won FDA clearance for its Spectrum IQ infusion system with Dose IQ safety software.

The company touted its system as the first of its kind to include bi-directional electronic medical records integration.

Get the full story at our sister site, Drug Delivery Business News.

The post Baxter wins FDA nod for Spectrum IQ infusion system appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply